Organon OGN
NYSE OGN
$13.73 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Organon (OGN) EBIT Margin (2020 - 2026)

Organon (OGN) posted quarterly EBIT Margin of 20.73% for Q2 2026, up 41.0% year-over-year from 14.7% in Q2 2025, and up 28.8% on a QoQ basis from 16.1% in Q1 2026.

Organon (OGN) EBIT Margin (2020 - 2026) Analysis & Trends

Organon has reported EBIT Margin for 7 years, with the latest figure at 20.73% in Q2 2026.

  • EBIT Margin for Q2 2026 came in at 20.73%, up 41.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 18.38% (down 171.0% YoY), and the FY2025 annual result was 18.19%, down 453.0% from the prior year.
  • EBIT Margin grew to 20.73% in Q2 2026, from 16.1% in the prior quarter.
  • Over five years, EBIT Margin peaked at 25.98% in Q3 2024 and troughed at 36.23% in Q4 2023.
  • A 5-year average of 2.41% and a median of 3.17% in 2022 frame the typical range for EBIT Margin.
  • The widest annual swing landed in 2023, when EBIT Margin slumped 1752 bps; it then soared 6100 bps in 2024.
  • A 5-year view of EBIT Margin shows it stood at 32.53% in 2022, then slipped by 11 bps to 36.23% in 2023, then jumped by 150 bps to 18.09% in 2024, then dropped by 23 bps to 13.93% in 2025, then soared by 49 bps to 20.73% in 2026.
  • Per Business Quant data, the three most recent EBIT Margin figures were 20.73% in Q2 2026, 16.1% in Q1 2026, and 13.93% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 28.21%
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn 37.86%
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn -3.52%
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn 32.97%
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn 20.57%
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 34.95%
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn -133.21%
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 28.37%
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn 5.72%
10 Organon 3.61 Bn 2.47 Bn 847.00 Mn 20.73%

Historic Data

Download Data
DateValue
Jun 30, 2026 20.73%
Mar 31, 2026 16.10%
Dec 31, 2025 13.93%
Sep 30, 2025 22.35%
Jun 30, 2025 20.33%
Mar 31, 2025 15.80%
Dec 31, 2024 18.09%
Sep 30, 2024 25.98%
Jun 30, 2024 24.02%
Mar 31, 2024 -26.45%
Dec 31, 2023 -36.23%
Sep 30, 2023 -35.02%
Jun 30, 2023 -24.00%
Mar 31, 2023 -22.43%
Dec 31, 2022 -32.53%
Sep 30, 2022 -17.50%
Jun 30, 2022 -18.99%
Mar 31, 2022 -7.59%
Dec 31, 2021 -22.65%
Sep 30, 2021 -13.75%